 |
PDBsum entry 1gjh
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Solution structure of the antiapoptotic protein bcl-2.
|
 |
|
Authors
|
 |
A.M.Petros,
A.Medek,
D.G.Nettesheim,
D.H.Kim,
H.S.Yoon,
K.Swift,
E.D.Matayoshi,
T.Oltersdorf,
S.W.Fesik.
|
 |
|
Ref.
|
 |
Proc Natl Acad Sci U S A, 2001,
98,
3012-3017.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The structures of two isoforms of Bcl-2 that differ by two amino acids have been
determined by NMR spectroscopy. Because wild-type Bcl-2 behaved poorly in
solution, the structures were determined by using Bcl-2/Bcl-x(L) chimeras in
which part of the putative unstructured loop of Bcl-2 was replaced with a
shortened loop from Bcl-x(L). These chimeric proteins have a low pI compared
with the wild-type protein and are soluble. The structures of the two Bcl-2
isoforms consist of 6 alpha-helices with a hydrophobic groove on the surface
similar to that observed for the homologous protein, Bcl-x(L). Comparison of the
Bcl-2 structures to that of Bcl-x(L) shows that although the overall fold is the
same, there are differences in the structural topology and electrostatic
potential of the binding groove. Although the structures of the two isoforms of
Bcl-2 are virtually identical, differences were observed in the ability of the
proteins to bind to a 25-residue peptide from the proapoptotic Bad protein and a
16-residue peptide from the proapoptotic Bak protein. These results suggest that
there are subtle differences in the hydrophobic binding groove in Bcl-2 that may
translate into differences in antiapoptotic activity for the two isoforms.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Sequence alignment of full-length Bcl-x[L], the
three isoforms of full-length Bcl-2 [denoted Bcl-2(1) (1,2),
Bcl-2(2) (3,4), and Bcl-2(3) (5,6)], and the truncated
Bcl-2/Bcl-x[L] chimeras used in this study. Amino acid
differences between the Bcl-2 isoforms are shown in red, the
truncated loop is shown in green, and the putative
membrane-spanning region is shown in blue. -helices
previously identified in Bcl-x[L] are denoted above the sequence
in red.
|
 |
Figure 3.
Fig. 3. Solvent-accessible surface showing hydrophobic
groove for Bcl-2(1) (A) and Bcl-2(2) (B). Leucine, isoleucine,
valine, tyrosine, phenylalanine, and tryptophan residues are
colored yellow, aspartate and glutamate are colored red, and
lysine, arginine, and histidine are colored blue. All other
residue types are colored gray.
|
 |
|
 |
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Cloning and structural analysis of cdnas for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
|
 |
|
Authors
|
 |
M.L.Cleary,
S.D.Smith,
J.Sklar.
|
 |
|
Ref.
|
 |
Cell, 1986,
47,
19-28.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Alternative promoters and exons, Somatic mutation and deregulation of the bcl-2-Ig fusion gene in lymphoma.
|
 |
|
Authors
|
 |
M.Seto,
U.Jaeger,
R.D.Hockett,
W.Graninger,
S.Bennett,
P.Goldman,
S.J.Korsmeyer.
|
 |
|
Ref.
|
 |
Embo J, 1988,
7,
123-131.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |